Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(9):738; doi:10.1093/jnci/djk163
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Span, P. N.
Right arrow Articles by Sweep, F. C. G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Span, P. N.
Right arrow Articles by Sweep, F. C. G. J.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Re: p27Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy

Paul N. Span, Pieter H. de Mulder, Fred C. G. J. Sweep

Affiliations of authors: Departments of Chemical Endocrinology (PNS, FCGJS) and Medical Oncology (PHDM), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

Correspondence to: Paul N. Span, PhD, 479 Department of Chemical Endocrinology, Radboud University Nijmegen Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands (e-mail: p.span@ace.umcn.nl).

The first 10% of the full text of this article appears below.

Porter et al. (1) recently described their evaluation of the association between survival and p27Kip1and cyclin E immunohistochemical staining on tissue microarrays from 2123 breast cancer patients treated with doxorubicin and cyclophosphamide. Although p27Kip1 was statistically . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

p27Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy
Peggy L. Porter, William E. Barlow, I-Tien Yeh, Ming Gang Lin, Xiaopu P. Yuan, Elizabeth Donato, George W. Sledge, Charles L. Shapiro, James N. Ingle, Charles M. Haskell, Kathy S. Albain, James M. Roberts, Robert B. Livingston, and Daniel F. Hayes
J Natl Cancer Inst 2006 98: 1723-1731. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. Grabowski, J. Schrader, J. Wagner, D. Horsch, R. Arnold, C. N. Arnold, I. Georgieva, H. Stein, M. Zeitz, P. T. Daniel, et al.
Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors
Clin. Cancer Res., November 15, 2008; 14(22): 7378 - 7384.
[Abstract] [Full Text] [PDF]